Impact of LDLR and PCSK9 pathogenic variants in Japanese heterozygous familial hypercholesterolemia patients
Mika Hori(Nagoya University Hospital), Mariko Harada‐Shiba(Osaka University of Pharmaceutical Sciences), Hiroaki Masuda(Minamiaoyama Eye Clinic), Kiminori Hosoda(National Cerebral and Cardiovascular Center), Rieko Isoda(National Cerebral and Cardiovascular Center), Yoshihiro Miyamoto(Asahikawa City Hospital), Cheol Son(National Cerebral and Cardiovascular Center), Suguru Yamamoto(Niigata University), Atsushi Takahashi(Fukushima Medical University), Masatsune Ogura(National Cerebral and Cardiovascular Center), Naotaka Ohta(National Cerebral and Cardiovascular Center)
Cited by 55
Related Papers
Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations
|Nature Genetics|2015|2.8k
Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2017
|Journal of Atherosclerosis and Thrombosis|2018|821
SNPs in KCNQ1 are associated with susceptibility to type 2 diabetes in East Asian and European populations
|Nature Genetics|2008|728
Comparative genetic architectures of schizophrenia in East Asian and European populations
|Nature Genetics|2019|709